Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M., … Parulekar, W. R. (2022). Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. JAMA, 327(20), 1963. https://doi.org/10.1001/jama.2022.6147
Subjects:
Antineoplastic Agents
(MeSH)
Breast Neoplasms
(MeSH)
Metformin
(MeSH)
Role of AMP-Activated Protein Kinase in Cellular Metabolism
(OpenAlex Topic)
Impact of Obesity on Cancer Risk and Prognosis
(OpenAlex Topic)
Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer
(OpenAlex Topic)
Publication Type:
Article
Unique ID:
10.1001/jama.2022.6147
PMID:
Publication Date:
Data Source:
OpenAlex